Macquarie Group’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-911,519
| Closed | -$77.3M | – | 2045 |
|
|
2019
Q4 | $77.3M | Sell |
911,519
-206,136
| -18% | -$13.7M | 0.11% | 182 |
|
|
2019
Q3 | $55.9M | Sell |
1,117,655
-146,687
| -12% | -$5.85M | 0.09% | 226 |
|
|
2019
Q2 | $46.1M | Sell |
1,264,342
-445,964
| -26% | -$14.6M | 0.08% | 275 |
|
|
2019
Q1 | $47.8M | Sell |
1,710,306
-350,880
| -17% | -$8.27M | 0.08% | 260 |
|
|
2018
Q4 | $39.5M | Buy |
2,061,186
+502,279
| +32% | +$11.7M | 0.08% | 275 |
|
|
2018
Q3 | $46.6M | Buy |
1,558,907
+281,213
| +22% | +$10.6M | 0.08% | 280 |
|
|
2018
Q2 | $46.9M | Buy |
1,277,694
+127,686
| +11% | +$4.15M | 0.08% | 258 |
|
|
2018
Q1 | $37.9M | Buy |
1,150,008
+70,906
| +7% | +$2.22M | 0.07% | 302 |
|
|
2017
Q4 | $29.5M | Buy |
1,079,102
+101,051
| +10% | +$3.11M | 0.05% | 378 |
|
|
2017
Q3 | $36.2M | Buy |
978,051
+104,869
| +12% | +$3.87M | 0.07% | 300 |
|
|
2017
Q2 | $33.2M | Buy |
873,182
+268,282
| +44% | +$11.9M | 0.06% | 304 |
|
|
2017
Q1 | $29.6M | Buy |
604,900
+5,296
| +0.9% | +$242K | 0.05% | 344 |
|
|
2016
Q4 | $20.4M | Buy |
599,604
+41,994
| +8% | +$1.49M | 0.04% | 433 |
|
|
2016
Q3 | $21M | Sell |
557,610
-506,460
| -48% | -$19.1M | 0.04% | 398 |
|
|
2016
Q2 | $35.8M | Buy |
1,064,070
+647,253
| +155% | +$22.8M | 0.04% | 410 |
|
|
2016
Q1 | $13.2M | Buy |
416,817
+53,495
| +15% | +$1.75M | 0.03% | 469 |
|
|
2015
Q4 | $13.6M | Buy |
363,322
+31,448
| +9% | +$1.19M | 0.03% | 456 |
|
|
2015
Q3 | $12.6M | Buy |
331,874
+99,934
| +43% | +$3.51M | 0.03% | 454 |
|
|
2015
Q2 | $6.64M | Buy |
231,940
+77,681
| +50% | +$2.16M | 0.01% | 672 |
|
|
2015
Q1 | $4.32M | Buy |
154,259
+32,393
| +27% | +$910K | 0.01% | 787 |
|
|
2014
Q4 | $3.37M | Sell |
121,866
-21,327
| -15% | -$528K | 0.01% | 855 |
|
|
2014
Q3 | $3.2M | Buy |
143,193
+22,668
| +19% | +$576K | 0.01% | 847 |
|
|
2014
Q2 | $3.5M | Buy |
120,525
+10,590
| +10% | +$283K | 0.01% | 823 |
|
|
2014
Q1 | $3.12M | Buy |
109,935
+19,775
| +22% | +$654K | 0.01% | 850 |
|
|
2013
Q4 | $3.48M | Buy |
90,160
+51,920
| +136% | +$1.86M | 0.01% | 740 |
|
|
2013
Q3 | $1.28M | Buy |
38,240
+2,230
| +6% | +$71K | ﹤0.01% | 1096 |
|
|
2013
Q2 | $1.11M | Buy |
+36,010
| New | +$1.2M | ﹤0.01% | 1133 |
|
Other funds holding MDCO
Macquarie Group's MDCO Position: Q1 2020 in Review
Macquarie Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 911,519 shares — an estimated $77.3M sold.
Macquarie Group first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $77.3M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Macquarie Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Macquarie Group sold 911,519 Medicines Co shares in Q1 2020, an estimated $77.3M.
- Macquarie Group first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Macquarie Group's Medicines Co position peaked at $77.3M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Macquarie Group's 13F filing for Q1 2020, filed 15 May 2020.